Victor Boniface has scored twice as Bayer Leverkusen kept up its strong start to the season with a 4-1 win over Hoffenheim to move level on points with Bayern Munich at the top of the Bundesliga standings

NEW YORK Facebook owner Meta Platforms on Thursday gave employees a sneak peek at a series of AI

Honolulu officials have installed a new interpretive plaque for four large boulders in the center of Waikiki that honor Taihitian healers of dual male and female spirit

CINCINNATI--(BUSINESS WIRE)--Jun 27, 2023--

Damar Hamlin "has not been practicing" but is "in the building working," Buffalo Bills head coach Sean McDermott said in a press conference on Tuesday.

The Chicago White Sox could be sellers at the Aug. 1 MLB trade deadline but they reportedly won't get much value for one player in particular.The Chicago White Sox are in the midst of another less-than-ideal season. Entering July 4, they are 37-49 on the year but remain just 6.5 games behin...

North West would like to start wearing her parents' clothes and reveals what she hopes to do in her future career when she grows up as part of the reality TV dynasty.

What the papers say Many of the papers speculate over Kylian Mbappe‘s future after the striker told Paris St Germain he did not want to extend his contract beyond 2024. Metro says Manchester United will lead the race to sign the 24-year-old if Sheikh Jassim bin Hamad Al Thani completes his takeover at Old Trafford. The Times reports Real Madrid is the France international’s “most likely destination”, although Premier League clubs including Chelsea are expected to register their interest. Manchester City had also previously shown an interest in the forward but have since signed Erling Haaland. Elsewhere, Arsenal are seeking buyers for winger Nicolas Pepe and have no plans to reintegrate the £72 million club-record signing into their first-team squad ahead of next season, the Daily Telegraph says. The 28-year-old spent the 2022-23 campaign on loan at French side Nice. According to The Guardian, Romelu Lukaku has been offered a deal worth up to £20m a season by Al-Hilal, with Chelsea’s Hakim Ziyech, 30, and Pierre-Emerick Aubameyang, 33, and Manchester City’s Riyad Mahrez, 32, also being targeted by clubs in Saudi Arabia. Chelsea striker Lukaku spent last season on loan at Inter Milan. Social media round-up Players to watch Manu Kone: The Daily Mail reports that Aston Villa and Wolves are interested in Borussia Monchengladbach’s 22-year-old midfielder, who has also been linked with Liverpool. David Raya: The Evening Standard says Tottenham are close to agreeing personal terms with the 27-year-old Brentford goalkeeper and hope to negotiate a lower fee with the Bees, who want £40m. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

'However, there have been rumors circulating in recent months that the fallout from Spare ... has put a strain on them,' said author Kati Nicholl

HONG KONG Hong Kong's economic growth slowed in the second quarter from a year earlier, advance government data

It’s no secret that real estate companies and builders are having a pretty tough time at the moment.

A high-stakes lawsuit over the future of a widely used abortion drug is likely heading to the US Supreme Court, set to determine the fate of abortion rights access across the country for a second time within two years. Three Republican-appointed judges on a federal appeals court have determined that the federal government did not follow proper procedures when it amended regulations for a commonly used medication abortion drug in 2016. But the restrictions will not immediately take effect. The panel partially upheld a ruling from a Donald Trump-appointed federal judge in Texas, whose sweeping decision earlier this year threatened to strip access to the drug altogether. Nothing in the ruling from a three-judge panel on 16 August will go into effect until the nation’s highest court weighs in. Wednesday’s ruling argues that the US Food and Drug Administration unlawfully expanded access to mifepristone, which was first approved by the federal government more than 20 years ago. Mifepristone was first approved by the FDA in 2000 and is approved for use up to 10 weeks of pregnancy. A vast majority of abortions occur within the first nine weeks of pregnancy. From 2019 through 2020, nearly 93 per cent of all abortions were performed before the 13th week, according to the US Centers for Disease Control and Prevention. The drug – part of a two-drug protocol for medication abortions, the most common form of abortion care in the US – is the subject of a lawsuit from a group of anti-abortion activists represented by right-wing Christian legal group Alliance Defending Freedom, which joined efforts to overturn Roe v Wade at the Supreme Court last year. In April, US District Judge Matthew Kacsmaryk – a former right-wing activist lawyer who was appointed to the federal judiciary by Mr Trump – issued a ruling to suspend the FDA’s approval, which was immediately challenged by abortion rights advocates, providers, major medical groups, drug manufacturers and President Joe Biden’s administration. An initial ruling at the US Court of Appeals for the Fifth Circuit blocked part of that decision but struck down policies for mail-in prescriptions and rules that expanded the drug’s approval for pregnancies up to 10 weeks. On 21 April, the Supreme Court blocked the lower courts’ rulings from taking effect while the case plays out, retaining the status quo while the legal case plays out. Following the Supreme Court’s conservative supermajority decision to revoke a constitutional right to abortion care in Dobbs v Jackson Women’s Health Organization, at least 15 states – mostly across the US South – have effectively banned most abortions and imposed criminal penalties against providers. Abortion rights advocates and providers have warned that eliminating or restricting access to mifepristone could drastically impact an already-fragile landscape for abortion care. A ruling that undermines the FDA’s drug approval process could also open the door for other activist-driven legal battles over other drugs wrapped up in political debates, potentially inviting other destabilising lawsuits to Covid-19 vaccines, contraception, HIV medication, gender-affirming care, and other life-saving drugs. Read More What is mifepristone? The widely used pill in the abortion rights battle at the Supreme Court Abortion rights advocates win major victory in Ohio as voters reject GOP plan to thwart ballot measure Texas women detailed agonising pregnancies after being denied abortions. The state blames doctors Some abortion drug restrictions upheld by in a case bound for Supreme Court Akram criticizes Pakistan Cricket Board for leaving Imran Khan out of Independence Day video Netanyahu voices support for Israel's military after his allies and son lambaste security officials